PT  - JOURNAL ARTICLE
AU  - Chapman, Kenneth G.
TI  - Pfizer's DRUMBEAT Program
DP  - 1980 May 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - 217--233
VI  - 34
IP  - 3
4099  - http://journal.pda.org/content/34/3/217.short
4100  - http://journal.pda.org/content/34/3/217.full
SO  - PDA J Pharm Sci Technol1980 May 01; 34
AB  - Proposed large-volume parenterals (LVP’s) represent only one of many sets of complex new GMP regulations introduced in the 1970’s. Many require a variety of written procedures. Pfizer Inc., multinational producer of ethical and OTC pharmaceuticals (including component bulk chemicals), medical devices (critical and non-critical), cosmetics, food additive chemicals, medicated animal feed premixes, and other products, found most of its product line affected. Quality assurance’s DRUMBEAT system reduces all GMP’s into a simple package, permitting Pfizer to quickly match its thousands of written procedures, for example, against regulatory requirements. Versatility of the system makes it applicable to a wide variety of similar problems.